Skip to main content

Table 2 Anticoagulant on admission and indication

From: Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients

Anticoagulant (%)

 DOAC

115 (70.1)

 VKA

44 (26.8)

 LMWH

3 (1.8)

 Fondaparinux

2 (1.2)

Indication (%)

 AF

119 (72.5)

 VTE

41 (25)

 Metallic heart valve

2 (1.2)

 LV thrombus

2(1.2)

  1. VKA vitamin K antagonist, DOAC Direct acting oral anticoagulant, LMWH Low molecular weight heparin, AF Atrial Fibrillation, VTE venous thromboembolism, LV left ventricular
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us